Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
Has Anyone Gotten HIV When They Were on PrEP?

At least 300,000 individuals are now using PrEP worldwide, and only two incidents have been reported where individuals with verified adherence to the drug acquired HIV. Three additional cases have been reported with unconfirmed adherence, and three are currently under investigation.

Published
22 April 2018
From
The Body
Vaginal implant might stop HIV transmission

Scientists at the University of Waterloo have developed a promising new medical device that could help protect women from HIV. The technology consists of a vaginal implant that basically reduces the amount of targets the virus can latch onto during sex, and may prove a more effective measure than some anti-HIV drugs or condoms in fending off infections.

Published
17 April 2018
From
New Atlas
Can I use poppers if I’m in drug treatment? Advice from a substance use counselor

As a substance use counselor with the Stonewall Project at San Francisco AIDS Foundation, clients oftentimes ask me how (or if) poppers fit into substance use treatment. Are poppers a dangerous “gateway” drug that might cause a slip back into meth use? Or are they a relatively benign drug that’s unfairly targeted by abstinence-only groups?

Published
16 April 2018
From
BETA
Genetically Altered Broadly Neutralizing Antibodies Protect Monkeys from HIV-Like Virus

Single infusions of each modified bNAb protected two groups of six monkeys each against weekly exposures to simian-human immunodeficiency virus (SHIV) for up to 37 weeks, compared with a median of 3 weeks in 12 monkeys receiving no antibody.

Published
16 April 2018
From
NIAID press release
Zambia, South Africa prevention study finds those with herpes virus facing six times HIV risk

Communities’ HIV prevalence could be predicted “almost exactly” from prevalence of herpes virus, researchers find.

Published
14 April 2018
From
Science Speaks
Researchers ID four types of nonbiomedical PrEP failure

Serota and colleagues describe 14 men who became infected with HIV in their EleMENt study of 300 young BMSM in Atlanta, despite being offered PrEP, along with services to ease access to PrEP uptake. They rightly point out that, in addition to the rare biomedical PrEP failures that receive so much attention at scientific meetings, we should focus our attention on the other “typologies” of PrEP failure that occur once PrEP is offered: low PrEP adherence, PrEP discontinuation, PrEP contemplation without initiation and PrEP refusal.

Published
14 April 2018
From
Healio
The UN’s Internal Struggle with Drug Policy

Drug policy at UN level is complicated. The division between health and human rights-oriented entities and the entities dealing with drugs is obvious. Without fundamental changes to this system, expectations that change might come from the UN will remain low.

Published
13 April 2018
From
Volte Face
My PrEP story: Jamie (part 2)

When Jamie Jaxon came away from the European PrEP Summit he was determined to start making ripples. In his second My PrEP Story blog, Jamie says it’s time to get those conversations going.

Published
10 April 2018
From
Prepster
My PrEP story: Patrick (part 2)

In his second My PrEP Story blog Dr. Patrick Baxter talks about being on Gilead’s DISCOVER Trial. What’s the trial attempting to do? And why the lack of community consultation? And is he really using PrEP?

Published
10 April 2018
From
Prepster
What is PrEP on-demand dosing and is it suitable for me?

Some people are choosing to only take PrEP when they know they’re going to have anal sex. We look at the reasons why.

Published
09 April 2018
From
Gay Star News
← First12345...413Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.